📰 Alpn News
Page 2 - Alpn News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Alpn. Real-time updates on events, politics, business and more.
December 25, 2023
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) have received an average rating of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat reports. Six research analysts have rated the stock with a buy rating. The average 12-month price target among brokerages that have updated their coverage on […]
December 19, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) insider James Paul Rickey sold 11,600 shares of the company’s stock in a transaction dated Thursday, December 14th. The stock was sold at an average price of $19.00, for a total transaction of $220,400.00. The sale was disclosed in a filing with the Securities & Exchange […]
December 19, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report)’s stock price hit a new 52-week high during mid-day trading on Tuesday . The stock traded as high as $19.41 and last traded at $19.41, with a volume of 39483 shares changing hands. The stock had previously closed at $18.92. Wall Street Analyst Weigh In A […]
December 9, 2023
The first 8 newly-minted Licensed Nurse Practitioners graduated through a distance certification program.
December 6, 2023
Trexquant Investment LP acquired a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 42,773 shares of the biotechnology company’s stock, valued at approximately $440,000. Trexquant Investment LP owned 0.09% of […]
December 5, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) reached a new 52-week high on Monday . The stock traded as high as $16.33 and last traded at $16.02, with a volume of 747998 shares trading hands. The stock had previously closed at $15.63. Wall Street Analysts Forecast Growth Several equities analysts have recently weighed […]
December 5, 2023
ExodusPoint Capital Management LP bought a new position in shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) in the second quarter, HoldingsChannel reports. The firm bought 62,839 shares of the biotechnology company’s stock, valued at approximately $646,000. A number of other hedge funds and other institutional investors have also recently modified their holdings […]
November 29, 2023
Shares of Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Get Free Report) saw strong trading volume on Wednesday . 620,360 shares traded hands during mid-day trading, an increase of 129% from the previous session’s volume of 271,139 shares.The stock last traded at $15.96 and had previously closed at $15.07. Analyst Upgrades and Downgrades A number of […]
November 19, 2023
Alpine Immune Sciences, Inc. (NASDAQ:ALPN – Free Report) – Analysts at Wedbush upped their FY2023 earnings per share estimates for shares of Alpine Immune Sciences in a research report issued on Wednesday, November 15th. Wedbush analyst R. Driscoll now forecasts that the biotechnology company will earn ($0.96) per share for the year, up from their […]
November 13, 2023
Alpine Immune Sciences, Inc. (ALPN.NASDAQ) : Stock quote, stock chart, quotes, analysis, advice, financials and news for Stock Alpine Immune Sciences, Inc. | Nasdaq: ALPN | Nasdaq